92845 ⎘
Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton with carbon atoms of carboxamide groups and singly-bound oxygen atoms bound to carbon atoms of the same non-condensed six-membered aromatic ring having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
CRYSTALLINE EDG-2 RECEPTOR ANTAGONIST AND METHODS OF MAKING
#2NOVEL FLAVORS, FLAVOR MODIFIERS, TASTANTS, TASTE ENHANCERS, UMAMI OR SWEET TASTANTS, AND/OR ENHANCERS AND USE THEREOF
#3MODULATORS OF THE INTEGRATED STRESS PATHWAY
#4CRYSTALLINE EDG-2 RECEPTOR ANTAGONIST AND METHODS OF MAKING
#5Therapeutic compounds and methods of use thereof
#6Compounds and pharmaceutical composition associated with ubiquitination-proteasome system
#7Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
#8T1R HETERO-OLIGOMERIC TASTE RECEPTORS, CELL LINES THAT EXPRESS SAID RECEPTORS, AND TASTE COMPOUNDS
#9Compounds and pharmaceutical composition associated with ubiquitination-proteasome system
#10Modulators of the integrated stress pathway
#11Therapeutic compounds and methods of use thereof
#12Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
#13Therapeutic compounds and methods of use thereof
#14Metabotropic glutamate receptor positive allosteric modulators (PAMS) and uses thereof
#15T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
#16Therapeutic compounds and methods of use thereof
#17Metabotropic glutamate receptor positive allosteric modulators (PAMS) and uses thereof
#18ACYLAMINO-SUBSTITUTED FUSED CYCLOPENTANECARBOXYLIC ACID DERIVATIVES AND THEIR USE AS PHARMACEUTICALS
#194-membered ring carboxamides used as nematicides
#20Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
#21Use of T1R3 venus flytrap region polypeptide to screen for taste modulators
#22Substituted 4-aminocyclohexane derivatives
#23Oleanolic acid amidate derivatives, preparation methods and uses thereof
#24Benzamide derivative and use thereof
#25Amine derivative compounds for treating ophthalmic diseases and disorders
#26N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenase
#27Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
#28Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals
#29Polyphenol proteasome inhibitors, synthesis, and methods of use
#30Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes, and Parkinson's disease
#31Chimeric T1R taste receptor polypeptides and nucleic acid sequences encoding and cell lines that express said chimeric T1R polypeptides
#32Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's
#33N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
#34Substituted 4-aminocyclohexane derivatives
#35COMPOSITIONS COMPRISING GALLATES AND GALLAMIDES
#36T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
#37Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
#38Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals
#39Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as Alzheimer's disease, type 2 diabetes and Parkinson's disease
#40Substituted 4-aminocyclohexane derivatives
#41Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
#42Amine derivative compounds for treating ophthalmic diseases and disorders
#43Amine derivative compounds for treating ophthalmic diseases and disorders
#44Polyphenol proteasome inhibitors, synthesis, and methods of use
#45Substituted indanes, method for the production thereof, and use thereof as drugs
#46Substituted tetrahydronaphthalenes, method for the production thereof, and use thereof as drugs
#4711-Beta-Hydroxysteroid Dehydrogenase Type 1 Active Compounds
#48Chimeric T1R taste receptor polypeptides and nucleic acid sequences encoding and cell lines that express said chimeric T1R polypeptides
#49Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease
#50Acylamino-substituted fused cyclopentanecarboxylic acid derivatives and their use as pharmaceuticals
#51N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenase
#52N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenase
#53Haloallylamine inhibitors of SSAO/VAP-1 and uses therefor
#5411β-hydroxysteroid dehydrogenase type 1 active compounds
#55Process for the manufacture of dihydropteridinones
#56Intermediate compounds useful for the manufacture of dihydropteridinones
#57Acylated indanyl amines and their use as pharmaceuticals
#58Benzamide derivative
#59Compounds, compositions, and methods for the treatment of synucleinopathies
#60Polyphenol proteasome inhibitors, synthesis, and methods of use
#61PLANT DISEASE CONTROL AGENT, AND PLANT DISEASE CONTROL METHOD
#62NOVEL COMPOUNDS
#63Substituted benzoylamino-indan-2-carboxylic acids and related compounds
#64Amide compound and use thereof for controlling plant diseases
#65ACETYLENE DERIVATIVES
#66AMIDE COMPOUND AND USE THEREOF
#67Benzamide derivatives and uses related thereto
#68Amide compound and use thereof
#69Amide compound and use thereof for controlling plant diseases
#70Selective TR-β 1 agonist
#71Amine derivative compounds for treating ophthalmic diseases and disorders
#72SUBSTITUTED 4-AMINOCYCLOHEXANE DERIVATIVES
#73COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF AMYLOID DISEASES AND SYNUCLEINOPATHIES SUCH AS ALZHEIMER'S DISEASE, TYPE 2 DIABETES, AND PARKINSON'S DISEASE
#74Use of compounds and compositions for the treatment of amyloid diseases
#75Amide compounds and their use
#76Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
#77Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
#78Cyclopropyl aryl amide derivatives and uses thereof
#79Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease
#80Acetylene derivatives
#81Process for the manufacture of dihydropteridinones
#82Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex
#83Chimeric T1R taste receptor polypeptides and nucleic acid sequences encoding and cell lines that express said chimeric T1R polypeptides
#84Polyphenol proteasome inhibitors, synthesis, and methods of use
#85Compounds, compositions and methods for the treatment of synucleinopathies
#86Novel Compounds
#87Benzamide derivative
#88T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
#89Peroxisome proliferator activated receptor modulators
#90Acylated indanyl amines and their use as pharmaceuticals
#91High affinity small molecule C5a receptor modulators
#92Benzamide derivatives and uses related thereto
#932,3-Oxidosqualene-lanosterol cyclase inhibitors
#94Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
#95N-phenyl and N-benzyl enaminones and methods for using same